ID   O-342/DDP
AC   CVCL_5J47
DR   Wikidata; Q54931662
RX   PubMed=1744159;
RX   PubMed=2121738;
CC   Doubling time: ~24 hours (PubMed=1744159).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5847 ! O-342
SX   Female
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
RX   PubMed=1744159; DOI=10.1007/BF01613285;
RA   Chen G., Hutter K.-J., Bullerdiek J., Zeller W.J.;
RT   "Karyotypic change from heteroploidy to near diploidy associated with
RT   development of cisplatin resistance in a rat ovarian tumour cell
RT   line.";
RL   J. Cancer Res. Clin. Oncol. 117:539-542(1991).
//
RX   PubMed=2121738; DOI=10.1007/BF01612991;
RA   Chen G., Zeller W.J.;
RT   "In vitro investigations on induction and reversal of cisplatin
RT   resistance in a rat ovarian tumor cell line.";
RL   J. Cancer Res. Clin. Oncol. 116:443-447(1990).
//